Compounded hormone therapy is hormone medication mixed by a pharmacy for an individual patient rather than manufactured and FDA-approved as a standardized product. It is not FDA-approved, and major medical bodies recommend FDA-approved hormone therapy first because compounded versions have not been tested for safety and consistent dosing the same way. That does not make it categorically unsafe, but it does mean the evidence behind it is weaker and the dosing is less predictable.

Key takeaways

  • "Compounded" and "bioidentical" are not the same thing. Bioidentical describes the hormone's structure; compounded describes how it is made. An FDA-approved estradiol patch is also bioidentical.
  • Compounded hormone therapy is not FDA-approved. The FDA reviews standardized, mass-produced drugs, not a cream mixed for one person.
  • The largest independent review (the National Academies, 2020) found the safety and effectiveness evidence for compounded hormones comes mostly from low-quality data, and recommended restricting routine use.
  • ACOG and The Menopause Society both recommend FDA-approved hormone therapy over compounded when an FDA-approved option exists.
  • Compounding has a legitimate, narrow role: a documented allergy to an ingredient in the FDA-approved product, or a dose or combination that is not commercially made.
  • The form matters. Transdermal creams under physician oversight are a more defensible choice than pellets, which have been linked to unpredictable, excessive hormone levels.
  • All estrogen therapy, compounded or not, carries real risks: blood clots, stroke, and breast cancer. A physician should review your history first.

"Is it safe" is the right question to ask before starting any hormone therapy, and compounded hormones deserve a straight answer rather than either the marketing gloss ("natural, personalized, safer") or a flat dismissal. Between 1 and 2.5 million American women over 40 use compounded hormones, so this is not a fringe choice. Therisse is a physician-led practice that prescribes a compounded option, and the honest version of this answer is below, including where the medical consensus disagrees with us.

What does "compounded hormone therapy" mean?

A compounding pharmacy mixes a medication to order for a specific patient, based on a prescription, instead of dispensing a pre-made manufactured product. Compounded hormone therapy (often marketed as "compounded bioidentical hormone therapy," or cBHT) usually means estrogens (estradiol, estriol), progesterone, or testosterone prepared as a cream, gel, capsule, troche, or pellet.

Two words get tangled together, so it is worth separating them:

  • Bioidentical describes the molecule: a hormone with the same chemical structure as the one your body makes. This is a property, not a quality stamp. Several FDA-approved products (estradiol patches, gels, and micronized progesterone capsules) are bioidentical too.
  • Compounded describes how it is made: mixed by a pharmacy for one patient, outside the FDA approval process.

Marketing often blurs the two so that "bioidentical" sounds like a benefit unique to compounding. It is not. The real distinction that affects safety is the second one: compounded versus FDA-approved.

Is compounded hormone therapy safe? The honest answer

The honest answer is that compounded hormone therapy has not been proven safe and effective to the same standard as FDA-approved hormone therapy, because it has not been tested the same way. That is different from saying it is dangerous. It means the evidence is thinner and the dosing is less predictable, so more of the safety depends on how it is prescribed and overseen.

The specific, documented concerns that medical bodies raise about compounded hormones:

  • No premarket testing for safety, efficacy, or consistent dosing. FDA-approved drugs go through that review; compounded preparations do not.
  • Dose can vary. Without standardized manufacturing, the amount of hormone actually delivered can be higher or lower than intended, batch to batch or pharmacy to pharmacy.
  • Quality and purity oversight is lighter. The Menopause Society notes concerns including minimal government monitoring, potential impurities, and lack of sterility in some settings.
  • No standardized label of risks. FDA-approved hormone therapy comes with required warnings; a compounded preparation may not.

None of that is a reason to panic if you are using a compounded cream prescribed and monitored by a physician. It is the reason the choice should be made with a clinician who is honest about the trade-off, not bought off a website that calls it "natural."

What do the medical guidelines actually say?

Three independent reviews land in the same place, and it is worth quoting their direction plainly rather than paraphrasing it into something softer.

  • The National Academies of Sciences, Engineering, and Medicine (NASEM), 2020. At the FDA's request, NASEM reviewed the evidence and found that information on the safety and effectiveness of compounded hormones came mostly from low-quality sources (anecdotal claims, patient reports, prescriber testimony), with a lack of rigorous clinical data. It recommended restricting the use of compounded hormone therapy.
  • The American College of Obstetricians and Gynecologists (ACOG), Clinical Consensus No. 6, 2023. ACOG advises clinicians to counsel patients that FDA-approved menopausal hormone therapies are recommended over compounded ones, and that compounded products should not be prescribed routinely when an FDA-approved formulation exists.
  • The Menopause Society (formerly NAMS). It describes compounded bioidentical therapy as carrying safety concerns including minimal regulation, over- or underdosing, possible impurities, and a lack of efficacy and safety data.

So the mainstream position is consistent: when an FDA-approved option fits, prefer it. A practice that prescribes a compounded product (including Therisse) should be able to say where it agrees with that and where its patients have a genuine reason to choose otherwise. We do that below.

Are compounded hormones FDA-approved?

No. Compounded hormones are not FDA-approved, and no honest practice should tell you otherwise.

There is a nuance worth understanding so the "not FDA-approved" line does not get over-read. The individual hormones used (estradiol, estriol, progesterone) are not unknown or unregulated substances. The issue is that the finished compounded product, mixed for you, is not reviewed by the FDA as a standardized drug for safety, effectiveness, and consistent dosing. FDA approval applies to a specific manufactured product made the same way every time, which a one-off compounded preparation by definition is not.

Compounding pharmacies that make these for individual prescriptions are known as 503A pharmacies, regulated mainly at the state board of pharmacy level, with FDA oversight of certain standards. (Larger 503B outsourcing facilities operate under stricter FDA manufacturing rules but serve a different, bulk role.) Therisse's compounded prescriptions are dispensed by a licensed 503A pharmacy.

When does compounded hormone therapy actually make sense?

There is a legitimate, narrow place for compounding that even its critics recognize. The FDA's own framework allows 503A compounding when there is a real clinical reason a commercially available product will not work, specifically:

  • A documented allergy or sensitivity to an inactive ingredient (a dye, a preservative) in the FDA-approved product.
  • A dose, strength, or combination that is not commercially manufactured, so no approved product matches what the patient needs.

What is not a legitimate reason, by that same framework, is compounding simply to make a cheaper or "custom" copy of a product that already exists in FDA-approved form. The clinical difference has to be real.

This is the honest test to apply to any practice offering compounded hormones: can they explain the specific reason compounding fits you, beyond "it's personalized"? Estriol, for example, is a second estrogen that no single FDA-approved menopause product contains, which is a concrete reason some women and clinicians choose a compounded biest formulation. That is a real distinction, not a marketing one.

What about pellets and saliva testing?

Not all compounded hormone therapy carries the same risk, and two practices deserve a specific caution.

  • Pellets. Compounded hormone pellets are implanted under the skin and release hormone over months. Both ACOG and The Menopause Society advise against them. The problem is delivery: pellets can produce unpredictable, often supraphysiologic (higher than normal) hormone levels that cannot be dialed back once the pellet is in, and the FDA's adverse-event database has recorded harms tied to excessive dosing from compounded pellets.
  • Saliva and blood hormone "testing" to customize doses. Marketing often pairs compounded hormones with frequent saliva or blood testing to "tailor" your dose. Major bodies find these tests have very limited use for guiding menopause treatment, because hormone levels fluctuate and do not map neatly onto symptoms or the right dose.

If you are evaluating a compounded option, a daily transdermal cream prescribed at a conservative starting strength and adjusted by a physician based on your symptoms is a more defensible approach than a pellet implant or a dose driven by saliva tests.

How to use compounded hormone therapy more safely

If you and a clinician decide a compounded option is right for you, several things separate a reasonable use from a risky one:

  • Transdermal over oral or pellet. Skin-applied estrogen skips the liver "first pass" associated with higher clot risk from oral estrogen, and a cream (unlike a pellet) can be adjusted or stopped.
  • A conservative starting dose, then titration. Because compounded dosing is less precisely characterized, starting low and adjusting to your response is safer than assuming a dose is "enough."
  • A reputable 503A pharmacy with proper sterility and quality practices.
  • Real physician oversight, including a review of your personal and family history of blood clots, stroke, and hormone-sensitive cancers before you start, not just a form.
  • The same risk awareness as any hormone therapy. Compounded or not, estrogen therapy carries established risks of blood clots, stroke, and breast cancer. "Bioidentical" and "natural" do not remove those risks.

How Therisse handles this

Therisse prescribes a compounded biest (estriol and estradiol) cream, dispensed by a licensed 503A pharmacy, after a board-certified physician reviews your intake and history. We try to do the things this article describes as the safer version of compounding: a transdermal cream rather than pellets, a conservative defensible starting strength (biest 80/20, 2.5 mg/gm) that is then adjusted to your response, a reputable compounding pharmacy, and physician review before anything is prescribed.

We also will not tell you compounded is FDA-approved or that it is safer than the FDA-approved alternative. It is not. The mainstream guideline position is that FDA-approved hormone therapy comes first, and if a physician judges that an FDA-approved patch or pill is the better fit for you, that is the right outcome. What a compounded option offers is the estriol component and the ability to tailor strength, for the women for whom that genuinely matters. (See the deeper biest cream vs estradiol patch comparison.)

Prescription products require an online consultation with a licensed provider. If a physician does not approve you, your initial consult fee and any medication charge are refunded in full.

Compounded products are not FDA-approved. This page is educational and is not medical advice. Hormone therapy is not right for everyone, and it carries risks including blood clots, stroke, and breast cancer. Talk to a licensed clinician about your individual history.

Frequently asked questions

Is compounded hormone therapy safe? It has not been tested for safety and consistent dosing to the same standard as FDA-approved hormone therapy, so the evidence behind it is weaker and the dose is less predictable. That does not make it categorically unsafe, but it means safety depends heavily on the form used and on real physician oversight. Major medical bodies recommend FDA-approved hormone therapy first.

Are compounded hormones the same as bioidentical hormones? Not exactly. "Bioidentical" describes the hormone's structure (matching the body's own), while "compounded" describes how it is made (mixed for one patient, outside FDA approval). Some FDA-approved products are bioidentical too, so the terms are not interchangeable.

Are compounded hormones FDA-approved? No. The finished compounded preparation is not FDA-approved. It is mixed for an individual patient by a compounding pharmacy and is not reviewed as a standardized product the way a manufactured drug is.

Is compounded hormone therapy safer or more natural than regular HRT? No. There is no good evidence that compounded "bioidentical" hormones are safer or more natural than FDA-approved hormone therapy, and "natural" does not remove the real risks of estrogen therapy (blood clots, stroke, breast cancer). Major medical organizations recommend FDA-approved options first.

Why do doctors prescribe compounded hormones at all if guidelines prefer FDA-approved? Because there are legitimate reasons an FDA-approved product will not fit: an allergy to an ingredient in it, a dose that is not commercially made, or a combination (such as one including estriol) that no single approved product offers. The compounding should match a real clinical need, not just a "personalized" marketing claim.

Are compounded hormone pellets safe? Pellets are the form most criticized by ACOG and The Menopause Society. They can deliver unpredictable, excessively high hormone levels that cannot be reversed once implanted, and have been tied to documented adverse events. A transdermal cream that can be adjusted or stopped is a more cautious choice.

Sources